PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for cell therapy development. Our offering includes scalable, cost-effective disposable solutions designed to take you from benchtop R&D to large-scale cGMP manufacturing, and expert process development services to help solve cell culture challenges and accelerate your path to commercialization. To learn more, contact our sales team at [email protected] or visit our website at www.pbsbiotech.com
$17M sweet spot round size
2008
$17M
from 2 investors over 1 rounds
PBS Biotech raised $17M on February 6, 2025
Investors: BroadOak Capital Partners and Avego Management